Revealing the dark secrets of TP53-mutated AML
In this issue of Blood, Tashakori et al elucidated the genomic and proteomic features of TP53-mutated acute myeloid leukemia (AML), a disease with a dismal prognosis that is currently spread across several AML disease categories.